Home / News (Page 2)

News

Invectys at the Third International Symposium on Immuno...

Invectys at the Third International Symposium on Immunotherapy organised by The Institute for Cancer Vaccines & Immunotherapy (previously known as the Cancer…

Read more

Invectys at ASCO 2017 in Chicago : Clinical Oncology

Invectys attend ASCO 2017 meeting in Chicago  Invectys will be at the Annual Meeting is organized by American Society Of Clinical Oncology (ASCO). This meeting…

Read more

10th European Life Sciences Forum SachsForum (ELSCEO), ...

Invectys will attend the Sachs Forum in Zürich, 6. March –  7. March 2017   Meet Invectys there ! More information:  invest@invectys.com The 10th…

Read more

Invectys was at J.P. Morgan Conference in San Francisco

J.P. Morgan 35Th Annual Healthcare Conference 2017 San-Francisco…

Read more

Medicen et Invectys: success of the TelVac project

Medicen Paris Region et Invectys annoncent le succès du projet TelVac pour la recherche d’un candidat vaccin contre le cancer…

Read more

Success for the therapeutic vaccine INVAC-1 in cancer

With 7 million raised in the last year and excellent results in terms of tolerance and innocuity, Invectys opens up new hopes in cancer immunotherapy   Paris,…

Read more

Invectys strengthens its intellectual property

Invectys files a patent on the acquisition of antibodies against an immune checkpoint expressed in all types of cancers and strengthens its HLA-G intellectual property…

Read more

Invectys raises 7 million euros more for clinical devel...

With more than 17 million euros raised in total Invectys also benefits from 850,000€ in financing from Bpifrance. Invectys announces fundraising of an additional…

Read more